Beta-trace protein as a marker of GFR - History, indications, and future research

Clinical Biochemistry

Volumn 47, Issue 13-14, 2014, Pages 1188-1194

  Filler, Guido ^a   Kusserow, Carola ^a   Lopes, Laudelino ^a   Kobrzyński, Marta ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Beta trace protein; Creatinine; Cystatin C; Glomerular filtration rate (GFR)

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D-ISOMERASE;

BLOOD; CHEMISTRY; GLOMERULUS FILTRATION RATE; HUMAN; METABOLISM; PHYSIOLOGY;

BIOLOGICAL MARKERS; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS;

EID: 84901087574     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.04.027     Document Type: Article

References (113)

1. Hochwald G.M., Pepe A.J., Thorbecke G.J. Trace proteins in biological fluids. IV. Physicochemical properties and sites of formation of gamma-trace and beta-trace proteins. Proc Soc Exp Biol Med Soc Exp Biol Med 1967, 124:961-966.
2. Kuruvilla A.P., Hochwald G.M., Ghiso J., Castano E.M., Pizzolato M., Frangione B. Isolation and amino terminal sequence of beta-trace, a novel protein from human cerebrospinal fluid. Brain Res 1991, 565:337-340.
3. Harrington M.G., Aebersold R., Martin B.M., Merril C.R., Hood L. Identification of a brain-specific human cerebrospinal fluid glycoprotein, beta-trace protein. Appl Theor Electrophor 1993, 3:229-234.
4. Zahn M., Mader M., Schmidt B., Bollensen E., Felgenhauer K. Purification and n-terminal sequence of beta-trace, a protein abundant in human cerebrospinal fluid. Neurosci Lett 1993, 154:93-95.
5. Watanabe K., Urade Y., Mader M., Murphy C., Hayaishi O. Identification of beta-trace as prostaglandin d synthase. Biochem Biophys Res Commun 1994, 203:1110-1116.
6. White D.M., Mikol D.D., Espinosa R., Weimer B., Le Beau M.M., Stefansson K. Structure and chromosomal localization of the human gene for a brain form of prostaglandin d2 synthase. J Biol Chem 1992, 267:23202-23208.
7. Watanabe T., Narumiya S., Shimizu T., Hayaishi O. Characterization of the biosynthetic pathway of prostaglandin d2 in human platelet-rich plasma. J Biol Chem 1982, 257:14847-14853.
8. Hoffmann A., Conradt H.S., Gross G., Nimtz M., Lottspeich F., Wurster U. Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin d synthase. J Neurochem 1993, 61:451-456.
9. Urade Y., Hayaishi O. Prostaglandin d synthase: structure and function. Vitam Horm 2000, 58:89-120.
10. Kanaoka Y., Ago H., Inagaki E., Nanayama T., Miyano M., Kikuno R., et al. Cloning and crystal structure of hematopoietic prostaglandin d synthase. Cell 1997, 90:1085-1095.
11. Urade Y., Eguchi N. Lipocalin-type and hematopoietic prostaglandin d synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 2002, 68-69:375-382.
12. Tanaka T., Urade Y., Kimura H., Eguchi N., Nishikawa A., Hayaishi O. Lipocalin-type prostaglandin d synthase (beta-trace) is a newly recognized type of retinoid transporter. J Biol Chem 1997, 272:15789-15795.
13. Blodorn B., Mader M., Urade Y., Hayaishi O., Felgenhauer K., Bruck W. Choroid plexus: the major site of mrna expression for the beta-trace protein (prostaglandin d synthase) in human brain. Neurosci Lett 1996, 209:117-120.
14. Blodorn B., Bruck W., Tumani H., Michel U., Rieckmann P., Althans N., et al. Expression of the beta-trace protein in human pachymeninx as revealed by in situ hybridization and immunocytochemistry. J Neurosci Res 1999, 57:730-734.
15. Nagata N., Fujimori K., Okazaki I., Oda H., Eguchi N., Uehara Y., et al. De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin d synthase, beta-trace, in the kidneys. FEBS J 2009, 276:7146-7158.
16. Olsson J.E., Nord L. Immunochemical and immunofluorescence studies of beta-trace protein in different species and organs, with special reference to the central nervous system. J Neurochem 1973, 21:625-633.
17. Urade Y., Hayaishi O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin d synthase. Biochim Biophys Acta 2000, 1482:259-271.
18. Urade Y., Eguchi Y., Eguchi N., Kijima Y., Matsuura Y., Oda H., et al. Secretion of lipocalin-type prostaglandin d synthase (beta-trace) from human heart to plasma during coronary circulation. Adv Exp Med Biol 1999, 469:49-54.
19. Eguchi Y., Eguchi N., Oda H., Seiki K., Kijima Y., Matsu-ura Y., et al. Expression of lipocalin-type prostaglandin d synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci U S A 1997, 94:14689-14694.
20. Hoffmann A., Nimtz M., Conradt H.S. Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology 1997, 7:499-506.
21. Huang S.H., Sharma A.P., Yasin A., Lindsay R.M., Clark W.F., Filler G. Hyperfiltration affects accuracy of creatinine egfr measurement. Clin J Am Soc Nephrol 2011, 6:274-280.
22. Li W., Mase M., Inui T., Shimoda M., Isomura K., Oda H., et al. Pharmacokinetics of recombinant human lipocalin-type prostaglandin d synthase/beta-trace in canine. Neurosci Res 2008, 61:289-293.
23. 125i-labelled beta-trace protein, with special reference to synthesis within the central nervous system. J Neurochem 1973, 21:1153-1159.
24. Filler G., Bokenkamp A., Hofmann W., Le Bricon T., Martinez-Bru C., Grubb A. Cystatin c as a marker of gfr-history, indications, and future research. Clin Biochem 2005, 38:1-8.
25. Garcia-Fernandez L.F., Rausell E., Urade Y., Hayaishi O., Bernal J., Munoz A. Hypothyroidism alters the expression of prostaglandin d2 synthase/beta trace in specific areas of the developing rat brain. Eur J Neurosci 1997, 9:1566-1573.
26. Garcia-Fernandez L.F., Urade Y., Hayaishi O., Bernal J., Munoz A. Identification of a thyroid hormone response element in the promoter region of the rat lipocalin-type prostaglandin d synthase (beta-trace) gene. Brain Res Mol Brain Res 1998, 55:321-330.
27. White D.M., Takeda T., DeGroot L.J., Stefansson K., Arnason B.G. Beta-trace gene expression is regulated by a core promoter and a distal thyroid hormone response element. J Biol Chem 1997, 272:14387-14393.
28. Ye Y., Gai X., Xie H., Jiao L., Zhang S. Impact of thyroid function on serum cystatin c and estimated glomerular filtration rate: a cross-sectional study. Endocr Pract 2013, 19:397-403.
29. Selvin E., Juraschek S.P., Eckfeldt J., Levey A.S., Inker L.A., Coresh J. Within-person variability in kidney measures. Am J Kidney Dis 2013, 61:716-722.
30. Tin A., Astor B.C., Boerwinkle E., Hoogeveen R.C., Coresh J., Kao W.H. Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans. Nephrol Dial Transplant 2013, 28:1497-1504.
31. van den Anker J.N., Allegaert K. Pharmacokinetics of aminoglycosides in the newborn. Curr Pharm Des 2012, 18:3114-3118.
32. Filler G., Browne R., Seikaly M.G. Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children. Pediatr Transplant 2003, 7:18-24.
33. Filler G., Yasin A., Medeiros M. Methods of assessing renal function. Pediatr Nephrol 2014, 29:183-192.
34. Filler G., Huang S.H., Yasin A. The usefulness of cystatin c and related formulae in pediatrics. Clin Chem Lab Med 2012, 50:2081-2091.
35. Filler G., Priem F., Vollmer I., Gellermann J., Jung K. Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate. Pediatr Nephrol 1999, 13:501-505.
36. Priem F., Althaus H., Birnbaum M., Sinha P., Conradt H.S., Jung K. Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem 1999, 45:567-568.
37. Melegos D.N., Grass L., Pierratos A., Diamandis E.P. Highly elevated levels of prostaglandin d synthase in the serum of patients with renal failure. Urology 1999, 53:32-37.
38. Priem F., Althaus H., Jung K., Sinha P. Beta-trace protein is not better than cystatin c as an indicator of reduced glomerular filtration rate. Clin Chem 2001, 47:2181.
39. Filler G., Priem F., Lepage N., Sinha P., Vollmer I., Clark H., et al. Beta-trace protein, cystatin c, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem 2002, 48:729-736.
40. Gowda S., Desai P.B., Kulkarni S.S., Hull V.V., Math A.A., Vernekar S.N. Markers of renal function tests. N Am J Med Sci 2010, 2:170-173.
41. Donadio C., Lucchesi A., Ardini M., Donadio E., Giordani R. Serum levels of beta-trace protein and glomerular filtration rate-preliminary results. J Pharm Biomed Anal 2003, 32:1099-1104.
42. Kobata M., Shimizu A., Rinno H., Hamada C., Maeda K., Fukui M., et al. Beta-trace protein, a new marker of gfr, may predict the early prognostic stages of patients with type 2 diabetic nephropathy. J Clin Lab Anal 2004, 18:237-239.
43. Woitas R.P., Stoffel-Wagner B., Poege U., Schiedermaier P., Spengler U., Sauerbruch T. Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem 2001, 47:2179-2180.
44. Huber A.R., Risch L. Recent developments in the evaluation of glomerular filtration rate: is there a place for beta-trace?. Clin Chem 2005, 51:1329-1330.
45. White C.A., Akbari A., Doucette S., Fergusson D., Hussain N., Dinh L., et al. A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem 2007, 53:1965-1968.
46. Benlamri A., Nadarajah R., Yasin A., Lepage N., Sharma A.P., Filler G. Development of a beta-trace protein based formula for estimation of glomerular filtration rate. Pediatr Nephrol 2010, 25:485-490.
47. White C.A., Akbari A., Doucette S., Fergusson D., Hussain N., Dinh L., et al. Estimating gfr using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations. Kidney Int 2009, 76:784-791.
48. Vynckier L.L., Flore K.M., Delanghe S.E., Delanghe J.R. Urinary beta-trace protein as a new renal tubular marker. Clin Chem 2009, 55:1241-1243.
49. Ogawa M., Hirawa N., Tsuchida T., Eguchi N., Kawabata Y., Numabe A., et al. Urinary excretions of lipocalin-type prostaglandin d2 synthase predict the development of proteinuria and renal injury in oletf rats. Nephrol Dial Transplant 2006, 21:924-934.
50. Nakayama H., Echizen H., Gomi T., Shibuya Y., Nakamura Y., Nakano K., et al. Urinary lipocalin-type prostaglandin d synthase: a potential marker for early gentamicin-induced renal damage?. Ther Drug Monit 2009, 31:126-130.
51. Uehara Y., Makino H., Seiki K., Urade Y., L-PGDS Clinical Research Group of Kidney Urinary excretions of lipocalin-type prostaglandin d synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study. Nephrol Dial Transplant 2009, 24:475-482.
52. Donadio C. Serum and urinary markers of early impairment of gfr in chronic kidney disease patients: diagnostic accuracy of urinary beta-trace protein. Am J Physiol Renal Physiol 2010, 299:F1407-F1423.
53. Dajak M., Ignjatovic S., Stojimirovic B., Gajic S., Majkic-Singh N. Evaluation of renal damage by urinary beta-trace protein in patients with chronic kidney disease. Clin Lab 2011, 57:29-36.
54. Dajak M., Ignjatovic S., Stojimirovic B., Gajic S., Majkic-Singh N. Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease. Clin Chim Acta 2010, 411:1154-1155.
55. Dajak M., Ignjatović S., Stojimirović B., Gajić S., Majkić-Singh N. Beta-trace protein as a marker of renal dysfunction in patients with chronic kidney disease: comparison with other renal markers. J Med Biochem 2012, 29:66-72.
56. Spanaus K.S., Kollerits B., Ritz E., Hersberger M., Kronenberg F., von Eckardstein A., et al. Serum creatinine, cystatin c, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem 2010, 56:740-749.
57. Bhavsar N.A., Appel L.J., Kusek J.W., Contreras G., Bakris G., Coresh J., et al. Comparison of measured gfr, serum creatinine, cystatin c, and beta-trace protein to predict esrd in African Americans with hypertensive ckd. Am J Kidney Dis 2011, 58:886-893.
58. Gerhardt T., Poge U., Stoffel-Wagner B., Palmedo H., Sauerbruch T., Woitas R.P. Is beta-trace protein an alternative marker of glomerular filtration rate in liver transplant recipients?. Liver Int 2011, 31:1345-1351.
59. Chen H.H. Beta-trace protein versus cystatin c: which is a better surrogate marker of renal function versus prognostic indicator in cardiovascular diseases?. J Am Coll Cardiol 2011, 57:859-860.
60. Solichova P., Novackova L., Ochmanova R., Stejskal D. Assessment of serum beta-trace protein (btp) measurement in the prediction of glomerular filtration rate. Comparison with serum cystatin c. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006, 150:83-84.
61. Risch L., Saely C., Reist U., Reist K., Hefti M., Huber A.R. Course of glomerular filtration rate markers in patients receiving high-dose glucocorticoids following subarachnoidal hemorrhage. Clin Chim Acta 2005, 360:205-207.
62. Abbink F.C., Laarman C.A., Braam K.I., van Wijk J.A., Kors W.A., Bouman A.A., et al. Beta-trace protein is not superior to cystatin c for the estimation of gfr in patients receiving corticosteroids. Clin Biochem 2008, 41:299-305.
63. Filler G., Berard R.A., Huang S.H. Ace levels may affect cystatin c measurements. Clin Biochem 2014, 47:129-131.
64. Filler G., Lopes L., Harrold J., Bariciak E. Beta-trace protein may be a more suitable marker of neonatal renal function. Clin Nephrol Apr. 2014, 81(4):269-276.
65. Inoue T., Eguchi Y., Matsumoto T., Kijima Y., Kato Y., Ozaki Y., et al. Lipocalin-type prostaglandin d synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis 2008, 201:385-391.
66. Tangri N., Inker L.A., Tighiouart H., Sorensen E., Menon V., Beck G., et al. Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol 2012, 23:351-359.
67. Manzano-Fernandez S., Lopez-Cuenca A., Januzzi J.L., Parra-Pallares S., Mateo-Martinez A., Sanchez-Martinez M., et al. Usefulness of beta-trace protein and cystatin c for the prediction of mortality in non-st segment elevation acute coronary syndromes. Am J Cardiol 2012, 110:1240-1248.
68. Astor B.C., Shaikh S., Chaudhry M. Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate. Curr Opin Nephrol Hypertens 2013, 22:331-335.
69. Astor B.C., Shafi T., Hoogeveen R.C., Matsushita K., Ballantyne C.M., Inker L.A., et al. Novel markers of kidney function as predictors of esrd, cardiovascular disease, and mortality in the general population. Am J Kidney Dis 2012, 59:653-662.
70. Orenes-Pinero E., Manzano-Fernandez S., Lopez-Cuenca A., Marin F., Valdes M., Januzzi J.L. Beta-trace protein: from gfr marker to cardiovascular risk predictor. Clin J Am Soc Nephrol 2013, 8:873-881.
71. Vilchez J.A., Roldan V., Manzano-Fernandez S., Fernandez H., Aviles-Plaza F., Martinez-Hernandez P., et al. Beta-trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. Chest 2013, 144:1564-1570.
72. Shafi T., Parekh R.S., Jaar B.G., Plantinga L.C., Oberai P.C., Eckfeldt J.H., et al. Serum beta-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol 2012, 7:1435-1445.
73. Hirawa N., Uehara Y., Yamakado M., Toya Y., Gomi T., Ikeda T., et al. Lipocalin-type prostaglandin d synthase in essential hypertension. Hypertension 2002, 39:449-454.
74. Cornelis T., Odutayo A., Keunen J., Hladunewich M. The kidney in normal pregnancy and preeclampsia. Semin Nephrol 2011, 31:4-14.
75. Conrad K.P. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J Soc Gynecol Investig 2004, 11:438-448.
76. Moran P., Baylis P.H., Lindheimer M.D., Davison J.M. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol 2003, 14:648-652.
77. Akbari A., Lepage N., Keely E., Clark H.D., Jaffey J., MacKinnon M., et al. Cystatin-c and beta trace protein as markers of renal function in pregnancy. BJOG 2005, 112:575-578.
78. Strevens H., Wide-Swensson D., Torffvit O., Grubb A. Serum cystatin c for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002, 62:141-147.
79. Strevens H., Wide-Swensson D., Grubb A. Serum cystatin c is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest 2001, 61:575-580.
80. Guo H.X., Wang C.H., Li Z.Q., Gong S.P., Zhou Z.Q., Leng L.Z., et al. The application of serum cystatin c in estimating the renal function in women with preeclampsia. Reprod Sci 2012, 19:712-717.
81. Kristensen K., Lindstrom V., Schmidt C., Blirup-Jensen S., Grubb A., Wide-Swensson D., et al. Temporal changes of the plasma levels of cystatin c, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process. Scand J Clin Lab Invest 2007, 67:612-618.
82. Lund U., Rippe A., Venturoli D., Tenstad O., Grubb A., Rippe B. Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol 2003, 284:F1226-F1234.
83. Rippe C., Asgeirsson D., Venturoli D., Rippe A., Rippe B. Effects of glomerular filtration rate on Ficoll sieving coefficients (theta) in rats. Kidney Int 2006, 69:1326-1332.
84. Helliwell R.J., Keelan J.A., Marvin K.W., Adams L., Chang M.C., Anand A., et al. Gestational age-dependent up-regulation of prostaglandin d synthase (pgds) and production of pgds-derived antiinflammatory prostaglandins in human placenta. J Clin Endocrinol Metab 2006, 91:597-606.
85. Shiki Y., Shimoya K., Tokugawa Y., Kimura T., Koyama M., Azuma C., et al. Changes of lipocalin-type prostaglandin d synthase level during pregnancy. J Obstet Gynaecol Res 2004, 30:65-70.
86. Melegos D.N., Diamandis E.P., Oda H., Urade Y., Hayaishi O. Immunofluorometric assay of prostaglandin d synthase in human tissue extracts and fluids. Clin Chem 1996, 42:1984-1991.
87. Melegos D.N., Yu H., Diamandis E.P. Prostaglandin d2 synthase: a component of human amniotic fluid and its association with fetal abnormalities. Clin Chem 1996, 42:1042-1050.
88. Kristensen K., Strevens H., Lindstrom V., Grubb A., Wide-Swensson D. Increased plasma levels of beta2-microglobulin, cystatin c and beta-trace protein in term pregnancy are not due to utero-placental production. Scand J Clin Lab Invest 2008, 68:649-653.
89. Cataldi L., Mussap M., Bertelli L., Ruzzante N., Fanos V., Plebani M. Cystatin c in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1999, 16:287-295.
90. Plebani M., Mussap M., Bertelli L., Moggi G., Ruzzante N., Fanos V., et al. Determination of blood cystatin c in pregnant women during labor and in their newborns. Pediatr Med Chir 1997, 19:325-329.
91. Strevens H., Wide-Swensson D., Grubb A., Hansen A., Horn T., Ingemarsson I., et al. Serum cystatin c reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG 2003, 110:825-830.
92. Deen W.M., Lazzara M.J., Myers B.D. Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 2001, 281:F579-F596.
93. McArthur J., Hill J., Paech M.J., Dodd P.H., Bennett E.J., Holden J. Cerebrospinal fluid and serum concentrations of beta-trace protein during pregnancy. Anaesthesia 2005, 60:163-167.
94. Lindheimer M.D., Umans J.G. Explaining and predicting preeclampsia. N Engl J Med 2006, 355:1056-1058.
95. Kristensen K., Wide-Swensson D., Schmidt C., Blirup-Jensen S., Lindstrom V., Strevens H., et al. Cystatin c, beta-2-microglobulin and beta-trace protein in pre-eclampsia. Acta Obstet Gynecol Scand 2007, 86:921-926.
96. Bariciak E., Yasin A., Harrold J., Walker M., Lepage N., Filler G. Preliminary reference intervals for cystatin c and beta-trace protein in preterm and term neonates. Clin Biochem 2011, 44:1156-1159.
97. Filler G.M. The challenges of assessing acute kidney injury in infants. Kidney Int 2011, 80:567-568.
98. Parvex P., Combescure C., Rodriguez M., Girardin E. Is cystatin c a promising marker of renal function, at birth, in neonates prenatally diagnosed with congenital kidney anomalies?. Nephrol Dial Transplant Sep. 2012, 27(9):3477-3482.
99. Bokenkamp A., Domanetzki M., Zinck R., Schumann G., Brodehl J. Reference values for cystatin c serum concentrations in children. Pediatr Nephrol 1998, 12:125-129.
100. Filler G., Grimmer J., Huang S.H., Bariciak E. Cystatin c for the assessment of gfr in neonates with congenital renal anomalies. Nephrol Dial Transplant Sep. 2012, 27(9):3382-3384.
101. Kristensen K., Larsson I., Hansson S.R. Increased cystatin c expression in the pre-eclamptic placenta. Mol Hum Reprod 2007, 13:189-195.
102. Abrahamson M., Olafsson I., Palsdottir A., Ulvsback M., Lundwall A., Jensson O., et al. Structure and expression of the human cystatin c gene. Biochem J 1990, 268:287-294.
103. Song G., Bailey D.W., Dunlap K.A., Burghardt R.C., Spencer T.E., Bazer F.W., et al. Cathepsin b, cathepsin l, and cystatin c in the porcine uterus and placenta: potential roles in endometrial/placental remodeling and in fluid-phase transport of proteins secreted by uterine epithelia across placental areolae. Biol Reprod 2010, 82:854-864.
104. Bokenkamp A., Franke I., Schlieber M., Duker G., Schmitt J., Buderus S., et al. Beta-trace protein-a marker of kidney function in children: "original research communication-clinical investigation". Clin Biochem 2007, 40:969-975.
105. Witzel S.H., Butts K., Filler G. Elevated triglycerides may affect cystatin c recovery. Clin Biochem May 2014, 47(7-8):676-678.
106. Delanghe J.R. How to establish glomerular filtration rate in children. Scand J Clin Lab Invest Suppl 2008, 241:46-51.
107. Pham-Huy A., Leonard M., Lepage N., Halton J., Filler G. Measuring glomerular filtration rate with cystatin c and beta-trace protein in children with spina bifida. J Urol 2003, 169:2312-2315.
108. Morgan C., Senthilselvan A., Bamforth F., Hoskinson M., Gowrishankar M. Correlation between cystatin c- and renal scan-determined glomerular filtration rate in children with spina bifida. Pediatr Nephrol 2008, 23:329-332.
109. Poge U., Gerhardt T., Stoffel-Wagner B., Palmedo H., Klehr H.U., Sauerbruch T., et al. Beta-trace protein-based equations for calculation of gfr in renal transplant recipients. Am J Transplant 2008, 8:608-615.
110. Poge U., Gerhardt T.M., Stoffel-Wagner B., Palmedo H., Klehr H.U., Sauerbruch T., et al. Beta-trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients. Clin Chem 2005, 51:1531-1533.
111. White C., Akbari A., Doucette S., Ferusson D., Hussain N., Dinh L., et al. Derivation and validation of a novel equation to estimate glomerular filtration rate in kidney transplant recipients using cystatin c and creatinine. American Journal of Transplantation 2008, 600. Blackwell Publishing, 9600 Garsington Rd, Oxford OX4 2DQ, Oxon, England.
112. White C.A., Akbari A., Doucette S., Fergusson D., Hussain N., Dinh L., et al. A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem 2007, 53:1965-1968.
113. White C.A., Akbari A., Doucette S., Fergusson D., Hussain N., Dinh L., et al. Estimating gfr using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations. Kidney Int 2009, 76:784-791.